Pharmacy

P Glitz Actos

Home » Prescription Drugs 12 » P Glitz Actos

Pioglitazone is an oral diabetes medicine that help control blood sugar levels. Pioglitazone is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes. Pioglitazone (pye-oh-GLI-ta-zone) is used to treat a certain type of diabetes mellitus (sugar diabetes) called type 2 diabetes. It may be used alone with insulin or with metformin or another type of oral diabetes medicine called a sulfonylurea. Pioglitazone is indicated as an adjunct to diet and exercise as a once-daily combination therapy to improve glycemic control in patients with type 2 diabetes who are already treated with a combination of pioglitazone and a sulfonylurea or whose diabetes is not adequately controlled with a sulfonylurea alone or for those patients who have initially responded to pioglitazone alone and require additional glycemic control. Management of type 2 diabetes should also include nutritional counseling weight reduction as needed and exercise. These efforts are important not only in the primary< treatment of type 2 diabetes but also to maintain the efficacy of drug therapy.

Buy P Glitz Actos and other Prescription Drugs 12 products online at Medstore.

Buy Online at Medstore - Click Here!

About P Glitz Actos:

Product Type: Prescription Drugs 12

P-Carzine (Matulane Generic Procarbazine)

P Glitz (Actos Duetact Generic Pioglitazone)

Actos Duetact Generic Pioglitazone

45mg Actos Duetact Generic Pioglitazone P Glitz

View more Prescription Drugs 12

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.